|
EXP001201
|
A gene delivery system for insect cells mediated by arginine-rich cell-penetrat…
|
2012 |
PR9
|
pDNA
|
yes |
yes |
|
no |
no |
|
EXP001202
|
Attachment of Cell-Binding Ligands to Arginine-Rich Cell-Penetrating Peptides E…
|
2015 |
9DR
|
siRNA
|
yes |
no |
no |
no |
no |
|
EXP001203
|
Attachment of Cell-Binding Ligands to Arginine-Rich Cell-Penetrating Peptides E…
|
2015 |
9LR
|
siRNA
|
yes |
no |
no |
no |
no |
|
EXP001204
|
Attachment of Cell-Binding Ligands to Arginine-Rich Cell-Penetrating Peptides E…
|
2015 |
RVG-9DR
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP001205
|
Attachment of Cell-Binding Ligands to Arginine-Rich Cell-Penetrating Peptides E…
|
2015 |
RVG-9LR
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP001206
|
Attachment of Cell-Binding Ligands to Arginine-Rich Cell-Penetrating Peptides E…
|
2015 |
scFvCD7-9DR
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001207
|
Attachment of Cell-Binding Ligands to Arginine-Rich Cell-Penetrating Peptides E…
|
2015 |
scFvCD7-9LR
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001208
|
The effect of dexamethasone/cell-penetrating peptide nanoparticles on gene deli…
|
2016 |
Arg8
|
pDNA
|
no |
yes |
|
no |
no |
|
EXP001209
|
The effect of dexamethasone/cell-penetrating peptide nanoparticles on gene deli…
|
2016 |
Arg8
|
pDNA
|
no |
yes |
|
no |
no |
|
EXP001210
|
The effect of dexamethasone/cell-penetrating peptide nanoparticles on gene deli…
|
2016 |
Arg8
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001211
|
The effect of dexamethasone/cell-penetrating peptide nanoparticles on gene deli…
|
2016 |
Arg8
|
pDNA
|
no |
yes |
|
no |
no |
|
EXP001212
|
Photochemically enhanced delivery of a cell-penetrating peptide nucleic acid co…
|
2007 |
Tat
|
ASO
|
yes |
yes |
|
no |
no |
|
EXP001213
|
Photochemically enhanced delivery of a cell-penetrating peptide nucleic acid co…
|
2007 |
Tat
|
ASO
|
no |
yes |
|
no |
no |
|
EXP001214
|
Photochemically enhanced delivery of a cell-penetrating peptide nucleic acid co…
|
2007 |
Tat
|
ASO
|
no |
no |
|
no |
no |
|
EXP001215
|
Widespread displacement of DNA- and RNA-binding factors underlies toxicity of a…
|
2021 |
(PR)20
|
oligonucleotide
|
yes |
no |
|
no |
no |
|
EXP001216
|
Widespread displacement of DNA- and RNA-binding factors underlies toxicity of a…
|
2021 |
(GR)20
|
oligonucleotide
|
yes |
no |
|
no |
no |
|
EXP001217
|
Widespread displacement of DNA- and RNA-binding factors underlies toxicity of a…
|
2021 |
(GA)20
|
oligonucleotide
|
yes |
no |
|
no |
no |
|
EXP001218
|
Widespread displacement of DNA- and RNA-binding factors underlies toxicity of a…
|
2021 |
(PK)20
|
oligonucleotide
|
yes |
no |
|
no |
no |
|
EXP001219
|
Nucleic Acids Delivery Into the Cells Using Pro-Apoptotic Protein Lactaptin
|
2019 |
RL2 (recombinant lactaptin)
|
pDNA
|
no |
yes |
|
no |
no |
|
EXP001220
|
Nucleic Acids Delivery Into the Cells Using Pro-Apoptotic Protein Lactaptin
|
2019 |
RL2 (recombinant lactaptin)
|
pDNA
|
no |
yes |
|
no |
no |
|
EXP001221
|
Nucleic Acids Delivery Into the Cells Using Pro-Apoptotic Protein Lactaptin
|
2019 |
RL2 (recombinant lactaptin)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001222
|
Nucleic Acids Delivery Into the Cells Using Pro-Apoptotic Protein Lactaptin
|
2019 |
RL2 (recombinant lactaptin)
|
RNA, unspecified
|
no |
yes |
|
no |
no |
|
EXP001223
|
Efficient antisense inhibition reveals microRNA-155 to restrain a late-myeloid …
|
2021 |
R8 (octaarginine)
|
anti-miRNA
|
yes |
yes |
|
no |
no |
|
EXP001224
|
Efficient antisense inhibition reveals microRNA-155 to restrain a late-myeloid …
|
2021 |
secR8 (secondary amphipathic R8 variant)
|
anti-miRNA
|
yes |
no |
|
no |
no |
|
EXP001225
|
Efficient antisense inhibition reveals microRNA-155 to restrain a late-myeloid …
|
2021 |
Pip6a (Pip CPP)
|
anti-miRNA
|
yes |
no |
|
no |
no |
|
EXP001226
|
Efficient antisense inhibition reveals microRNA-155 to restrain a late-myeloid …
|
2021 |
K3 (trilysine)
|
anti-miRNA
|
yes |
no |
|
no |
no |
|
EXP001227
|
Application of Cell-Penetrating Peptides (CPP) to Enhance the Efficacy of Antis…
|
2025 |
TP10 (Transportan 10)
|
ASO
|
yes |
no |
|
no |
no |
|
EXP001228
|
Application of Cell-Penetrating Peptides (CPP) to Enhance the Efficacy of Antis…
|
2025 |
TP10 (Transportan 10)
|
ASO
|
yes |
no |
|
no |
no |
|
EXP001229
|
Amphipathic Octenyl-Alanine Modified Peptides Mediate Effective siRNA Delivery
|
2025 |
hPep1
|
siRNA
|
yes |
no |
yes |
no |
no |
|
EXP001230
|
Amphipathic Octenyl-Alanine Modified Peptides Mediate Effective siRNA Delivery
|
2025 |
hPep2
|
siRNA
|
yes |
no |
yes |
no |
no |
|
EXP001231
|
Amphipathic Octenyl-Alanine Modified Peptides Mediate Effective siRNA Delivery
|
2025 |
hPep3
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP001232
|
Amphipathic Octenyl-Alanine Modified Peptides Mediate Effective siRNA Delivery
|
2025 |
Ctrl
|
siRNA
|
yes |
no |
yes |
no |
no |
|
EXP001233
|
Amphipathic Octenyl-Alanine Modified Peptides Mediate Effective siRNA Delivery
|
2025 |
hPep3
|
siRNA
|
no |
yes |
yes |
no |
no |
|
EXP001234
|
Amphipathic Octenyl-Alanine Modified Peptides Mediate Effective siRNA Delivery
|
2025 |
hPep3
|
siRNA
|
no |
|
|
yes |
no |
|
EXP001235
|
Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein a…
|
2014 |
9R (C3G9R4LC) + Cas9-m9R system
|
sgRNA
|
no |
yes |
|
no |
no |
|
EXP001236
|
Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein a…
|
2014 |
9R (C3G9R4LC) + Cas9-m9R system
|
sgRNA
|
no |
yes |
|
no |
no |
|
EXP001237
|
Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein a…
|
2014 |
9R (C3G9R4LC) + Cas9-m9R system
|
sgRNA
|
no |
yes |
|
no |
no |
|
EXP001238
|
Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein a…
|
2014 |
9R (C3G9R4LC) + Cas9-m9R system
|
sgRNA
|
no |
yes |
|
no |
no |
|
EXP001239
|
Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein a…
|
2014 |
9R (C3G9R4LC) + Cas9-m9R system
|
sgRNA
|
no |
yes |
|
no |
no |
|
EXP001240
|
Cellular delivery of small interfering RNA by a non-covalently attached cell-pe…
|
2006 |
MPGα
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001241
|
Cellular delivery of small interfering RNA by a non-covalently attached cell-pe…
|
2006 |
MPGα-mNLS
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001242
|
Improved cell-penetrating peptide–PNA conjugates for splicing redirection in He…
|
2008 |
R6Pen–PNA705
|
SCO
|
no |
yes |
|
no |
no |
|
EXP001243
|
Improved cell-penetrating peptide–PNA conjugates for splicing redirection in He…
|
2008 |
Pip1–PNA705
|
SCO
|
no |
yes |
|
no |
no |
|
EXP001244
|
Improved cell-penetrating peptide–PNA conjugates for splicing redirection in He…
|
2008 |
Pip2a–PNA705
|
SCO
|
no |
yes |
|
no |
no |
|
EXP001245
|
Improved cell-penetrating peptide–PNA conjugates for splicing redirection in He…
|
2008 |
Pip2b–PNA705
|
SCO
|
no |
yes |
|
no |
no |
|
EXP001246
|
Improved cell-penetrating peptide–PNA conjugates for splicing redirection in He…
|
2008 |
RXR4–PNA705
|
SCO
|
no |
yes |
|
no |
no |
|
EXP001247
|
Improved cell-penetrating peptide–PNA conjugates for splicing redirection in He…
|
2008 |
Pip1–PNADMD
|
SCO
|
no |
yes |
|
no |
no |
|
EXP001248
|
Improved cell-penetrating peptide–PNA conjugates for splicing redirection in He…
|
2008 |
Pip2a–PNADMD
|
SCO
|
no |
yes |
|
no |
no |
|
EXP001249
|
Improved cell-penetrating peptide–PNA conjugates for splicing redirection in He…
|
2008 |
Pip2b–PNADMD
|
SCO
|
no |
yes |
|
no |
no |
|
EXP001250
|
Improved cell-penetrating peptide–PNA conjugates for splicing redirection in He…
|
2008 |
RXR4–PNADMD
|
SCO
|
no |
yes |
|
no |
no |
|
EXP001251
|
Improved cell-penetrating peptide–PNA conjugates for splicing redirection in He…
|
2008 |
Pip1–PNADMD
|
SCO
|
no |
|
|
yes |
yes |
|
EXP001252
|
Improved cell-penetrating peptide–PNA conjugates for splicing redirection in He…
|
2008 |
Pip2a–PNADMD
|
SCO
|
no |
|
|
yes |
yes |
|
EXP001253
|
Improved cell-penetrating peptide–PNA conjugates for splicing redirection in He…
|
2008 |
Pip2b–PNADMD
|
SCO
|
no |
|
|
yes |
yes |
|
EXP001254
|
Improved cell-penetrating peptide–PNA conjugates for splicing redirection in He…
|
2008 |
RXR4–PNADMD
|
SCO
|
no |
|
|
yes |
yes |
|
EXP001255
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF14
|
pDNA
|
no |
yes |
|
no |
no |
|
EXP001256
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF14
|
pDNA
|
no |
yes |
|
no |
no |
|
EXP001257
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF14
|
pDNA
|
no |
yes |
|
no |
no |
|
EXP001258
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF14
|
pDNA
|
no |
yes |
|
no |
no |
|
EXP001259
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF14
|
pDNA
|
no |
yes |
|
no |
no |
|
EXP001260
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF14
|
pDNA
|
no |
yes |
|
no |
no |
|
EXP001261
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF221
|
pDNA
|
no |
yes |
|
no |
no |
|
EXP001262
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF221
|
pDNA
|
no |
yes |
|
no |
no |
|
EXP001263
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF221
|
pDNA
|
no |
yes |
|
no |
no |
|
EXP001264
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF221
|
pDNA
|
no |
yes |
|
no |
no |
|
EXP001265
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF221
|
pDNA
|
no |
yes |
|
no |
no |
|
EXP001266
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF221
|
pDNA
|
no |
yes |
|
no |
no |
|
EXP001267
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF14
|
ASO
|
yes |
yes |
|
no |
no |
|
EXP001268
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF14
|
ASO
|
yes |
yes |
|
no |
no |
|
EXP001269
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF14
|
ASO
|
yes |
yes |
|
no |
no |
|
EXP001270
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF14
|
ASO
|
yes |
yes |
|
no |
no |
|
EXP001271
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF14
|
ASO
|
yes |
yes |
|
no |
no |
|
EXP001272
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF14
|
ASO
|
yes |
yes |
|
no |
no |
|
EXP001273
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF221
|
ASO
|
no |
yes |
|
no |
no |
|
EXP001274
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF221
|
ASO
|
no |
yes |
|
no |
no |
|
EXP001275
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF221
|
ASO
|
no |
yes |
|
no |
no |
|
EXP001276
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF221
|
ASO
|
no |
yes |
|
no |
no |
|
EXP001277
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF221
|
ASO
|
no |
yes |
|
no |
no |
|
EXP001278
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF221
|
ASO
|
no |
yes |
|
no |
no |
|
EXP001279
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF14
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001280
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF14
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001281
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF14
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001282
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF14
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001283
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF14
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001284
|
Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks
|
2020 |
PF14
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001285
|
Chitosan enhances gene delivery of oligonucleotide complexes with magnetic nano…
|
2018 |
PF14
|
pDNA
|
no |
yes |
|
no |
no |
|
EXP001286
|
Chitosan enhances gene delivery of oligonucleotide complexes with magnetic nano…
|
2018 |
PF14
|
pDNA
|
no |
yes |
|
no |
no |
|
EXP001287
|
Chitosan enhances gene delivery of oligonucleotide complexes with magnetic nano…
|
2018 |
PF221
|
pDNA
|
no |
yes |
|
no |
no |
|
EXP001288
|
Chitosan enhances gene delivery of oligonucleotide complexes with magnetic nano…
|
2018 |
PF221
|
pDNA
|
no |
yes |
|
no |
no |
|
EXP001289
|
Chitosan enhances gene delivery of oligonucleotide complexes with magnetic nano…
|
2018 |
PF14
|
ASO
|
no |
yes |
|
no |
no |
|
EXP001290
|
Chitosan enhances gene delivery of oligonucleotide complexes with magnetic nano…
|
2018 |
PF14
|
ASO
|
yes |
yes |
|
no |
no |
|
EXP001291
|
Chitosan enhances gene delivery of oligonucleotide complexes with magnetic nano…
|
2018 |
PF221
|
ASO
|
no |
yes |
|
no |
no |
|
EXP001292
|
Chitosan enhances gene delivery of oligonucleotide complexes with magnetic nano…
|
2018 |
PF221
|
ASO
|
no |
yes |
|
no |
no |
|
EXP001293
|
Chitosan enhances gene delivery of oligonucleotide complexes with magnetic nano…
|
2018 |
PF14
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001294
|
Chitosan enhances gene delivery of oligonucleotide complexes with magnetic nano…
|
2018 |
PF14
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001295
|
Chitosan enhances gene delivery of oligonucleotide complexes with magnetic nano…
|
2018 |
PF221
|
siRNA
|
no |
|
|
no |
no |
|
EXP001296
|
Vitamin B12 as a carrier of peptide nucleic acid (PNA) into bacterial cells
|
2017 |
(KFF)3K
|
ASO
|
no |
yes |
|
no |
no |
|
EXP001297
|
Vitamin B12 as a carrier of peptide nucleic acid (PNA) into bacterial cells
|
2017 |
(KFF)3K
|
ASO
|
no |
yes |
|
no |
no |
|
EXP001298
|
Therapeutic Effects on Atopic Dermatitis by Anti-RelA Short Interfering RNA Com…
|
2011 |
Tat analog (CPP) + AT1002 analog (TJ modulator)
|
siRNA
|
yes |
|
|
yes |
no |
|
EXP001299
|
Therapeutic Effects on Atopic Dermatitis by Anti-RelA Short Interfering RNA Com…
|
2011 |
Tat analog (CPP) + AT1002 analog (TJ modulator)
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP001300
|
Non-transgenic Gene Modulation via Spray Delivery of Nucleic Acid/Peptide Compl…
|
2022 |
KH9-BP100
|
siRNA
|
no |
|
|
yes |
yes |